antibody-producing anti-cardiovascular disease gene therapy (Immusoft)

N/A

Report date: 2025/03/14 16:40:39

Base Information

Drug Nameantibody-producing anti-cardiovascular disease gene therapy (Immusoft)
Drug Alias Nameantibody-producing anti-cardiovascular disease lentiviral pseudotype gene therapy (Immusoft)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmusoft Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmusoft Corp
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A